Surface functionalization of superparamagnetic nanoparticles for the development of highly efficient magnetic

Chao Huang1, Koon Gee Neoh, Liang Wang

  • 1Department of Chemical and Biomolecular Engineering, National University of Singapore, Kent Ridge, Singapore 119260.

Insights

Superparamagnetic iron oxide nanoparticles (SPIONs) coated with poly(DL-lactic acid-co-malic acid) (PLMA) show promise for tracking macrophages in vivo using magnetic resonance imaging (MRI). These PLMA-SPIONs offer enhanced contrast and detect low numbers of labeled cells with minimal toxicity.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • In vivo magnetic resonance imaging (MRI) is crucial for monitoring diseases with high macrophage activity.
  • Developing effective contrast agents for macrophage tracking is essential for disease diagnosis and management.

Purpose of the Study:

  • To synthesize and characterize poly(DL-lactic acid-co-malic acid)-coated superparamagnetic iron oxide nanoparticles (PLMA-SPIONs).
  • To evaluate the efficacy of PLMA-SPIONs as contrast agents for in vitro and potentially in vivo macrophage tracking using MRI.

Main Methods:

  • Surface functionalization of superparamagnetic iron oxide nanoparticles (SPIONs) with PLMA using nanoprecipitation.
  • Characterization of PLMA-SPIONs' relaxivity (r(1), r(2), r(2)/r(1)) at 3 T.
  • Assessment of cellular uptake, iron quantification (ICP-MS), and cytotoxicity in macrophages.
  • Evaluation of MRI contrast enhancement and detection limits using a clinical 3 T MRI scanner.

Main Results:

  • PLMA-SPIONs exhibited a high r(2)/r(1) ratio (516 mM(-1) s(-1)), indicating enhanced MR contrast potential.
  • Macrophages readily internalized PLMA-SPIONs with no significant cytotoxicity observed.
  • A linear correlation was found between R(2)/R(2*) values and the number of labeled cells.
  • An in vitro detection threshold of approximately 2820 labeled cells was achieved.

Conclusions:

  • PLMA-SPIONs are effective MRI contrast agents for macrophage labeling and tracking.
  • The developed nanoparticles demonstrate low cytotoxicity and high cellular uptake.
  • These findings suggest PLMA-SPIONs hold potential for targeted macrophage imaging in disease monitoring.

Related Concept Videos